Back to search
FDAFDA · Food and drugs·Recall number D-1380-2012

DermaZinc Spray, 0.25% zinc pyritione, topical OTC, 4 fl oz bottle Distributed By: Dermallogix Partners, Inc. Scarborough, ME 04070

Published June 20, 2012 · Recall initiated: March 20, 2012

Summary

FDA records drug Class III recall D-1380-2012, published June 20, 2012 and initiated March 20, 2012. Recalling firm: Quadrant Chemical Corporation; Status: Terminated; Reported quantity: 4800 bottles; Lot: Lot 022110-01. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent (Single Ingredient Drug): The firm is recalling the product because the product is subpotent and does not meet the labeled 0.25% zinc pyrithione level.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Quadrant Chemical Corporation
Distributor
Maine
Lot
Lot 022110-01
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was DermaZinc Spray, 0.25% zinc pyritione, topical OTC, 4 fl oz bottle Distributed By: Dermallogix Partners, Inc. Scarborough, ME 04070 recalled?

Yes. FDA published recall D-1380-2012 on June 20, 2012. Reported hazard: Subpotent (Single Ingredient Drug): The firm is recalling the product because the product is subpotent and does not meet the labeled 0.25% zinc pyrithione level.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail